Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
14 August 2018
Media effectively used to save the giraffe
“If we can save the habitat wildlife need, then the animals will be just fine,” said Dr Francois Deacon, a wildlife habitat expert in the UFS Department of Animal, Wildlife and Grassland Sciences.

The University of the Free State (UFS) is leading the fight against the extinction of giraffes and has assembled the largest research team in the world to manage, coordinate, and address this issue. Seven UFS departments are involved in this research. 

Dr Francois Deacon, a wildlife habitat expert in the UFS Department of Animal, Wildlife and Grassland Sciences, is leading the team of researchers who tasked themselves with better understanding the giraffe, and in so doing, save the giraffe. He said: "One way to stop the plummeting numbers is to learn more about how giraffes use their habitat and how much area they need in order to survive."

Dr Deacon focuses on the spatial ecology of wild animals. His main research focus is to understand the ecological and biological factors that regulate giraffe in their natural habitat.

Documentaries save

He collaborated with a documentary film crew to release the second in a trilogy of documentaries regarding giraffes and their natural habitat. The first, Last of the Longnecks, focused on the fact that giraffes are becoming extinct. The second documentary, Catching Giants, which was released last year, includes footage on how a multi-specialist research group of over 30 people from 10 different countries worked together to collect information about these little-known animals.

Documentaries such as these, together with a recent insert in the local wildlife documentary on SABC 2, 50/50, also helped to raise awareness on the giraffe and its plight.

Telling the truth

Dr Deacon said: “It is extremely important for the public to see how involved we really are with a major problem such as a species becoming extinct. Media exposure outlines the truth of what man is doing to nature. Cooperating with media such as the BBC, National Geographic, and 50/50, offers other journalists, producers, editors, and authors the opportunity to also take responsibility for raising awareness on the issue.” 

“Apart from the fact that awareness is shedding light on the problem, it also highlights who the leaders in this field are, what they are doing to address the problem, and what more is needed to make a change. The latter includes the funding of postgraduate students to conduct further research on this matter. If we were able to gather sufficient knowledge through different research questions across the globe, we could really make a difference in saving giraffes from extinction.” 

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept